UK biotech sector calls on government to support sector’s growth on home soil
More than 100 stakeholders across the British bio-based sector, including businesses, investors, industry organisations and manufacturers, have written a letter…
More than 100 stakeholders across the British bio-based sector, including businesses, investors, industry organisations and manufacturers, have written a letter…
Massachusetts-based biotech venture firm Flagship Pioneering has initially committed £100m ($131m) to its UK presence by building a new company…
European venture capital (VC) giant, Sofinnova Partners, has closed a €725m ($815m) fund to support a range of life sciences…
In recent years, the European biotechnology sector has been thrust into a period of notable change, with new technologies and…
Swiss biotech company Neurosterix has banked $105m in a Series B funding round to push its range of neuropsychiatric candidates…
Eli Lilly has beaten its staunch obesity rival Novo Nordisk to market in China by securing an approval for its…
In recent years, the emergence of the incretin drug class has revolutionised the cardiometabolic treatment space, as doctors increasingly prescribe…
With the curtains closing on another year at BIO-Europe, the attending editorial team is still revelling in the interesting conversations…
After two years of fruitful collaboration, AstraZeneca is opting to acquire its partner and bacterial vaccine technology startup, Omniose. For…
On 4 November, the Democrats made history by winning the Senate and the House in the US midterm elections –…